spectinabilin: structure in first source
spectinabilin : A polyketide that is deoxyspectinabilin in which the tetramethyldeca-tetraen-1-yl chain attached to the 4-pyranone moiety has undergone oxidation at position 1 and at the methyl group at position 3 to afford the corresponding tetrahydrofuranyl moiety. Produced by Streptomyces spectabilis, it exhibits antiviral and antimalarial activity.
ID Source | ID |
---|---|
PubMed CID | 5352028 |
CHEMBL ID | 2005277 |
MeSH ID | M0495637 |
Synonym |
---|
4h-pyran-4-one,5-dimethyl-6-[tetrahydro-4-[2,4,6-trimethyl-7-(4-nitrophenyl)-2,4,6-heptatrienylidene]-2-furanyl]- |
2-methoxy-3,5-dimethyl-6-{(4z)-4-[(2e,4e,6e)-2,4,6-trimethyl-7-(4-nitrophenyl)hepta-2,4,6-trien-1-ylidene]tetrahydrofuran-2-yl}-4h-pyran-4-one |
spectinabilin |
NSC260179 , |
2-methoxy-3,5-dimethyl-6-[(4z)-4-[(2e,4e,6e)-2,4,6-trimethyl-7-(4-nitrophenyl)hepta-2,4,6-trienylidene]tetrahydrofuran-2-yl]pyran-4-one |
2-methoxy-3,5-dimethyl-6-[(4z)-4-[(2e,4e,6e)-2,4,6-trimethyl-7-(4-nitrophenyl)hepta-2,4,6-trienylidene]oxolan-2-yl]pyran-4-one |
nsc 260179 |
unii-nh93bw6naq |
4h-pyran-4-one, 2-methoxy-3,5-dimethyl-6-((4z)-tetrahydro-4-((2e,4e,6e)-2,4,6-trimethyl-7-(4-nitrophenyl)-2,4,6-heptatrienylidene)-2-furanyl)- |
nh93bw6naq , |
CHEMBL2005277 |
neoaureothin* |
IZICQJAGBLBAMJ-MNOZRKQQSA-N |
4h-pyran-4-one, 2-methoxy-3,5-dimethyl-6-[tetrahydro-4-[2,4,6-trimethyl-7-(p-nitrophenyl)-2,4,6-heptatrienylidene]-2-furyl]-, (+)- |
2-methoxy-3,5-dimethyl-6-((4z)-4-[(2e,4e,6e)-2,4,6-trimethyl-7-(4-nitrophenyl)-2,4,6-heptatrienylidene]tetrahydro-2-furanyl)-4h-pyran-4-one # |
4h-pyran-4-one, 2-methoxy-3,5-dimethyl-6-[tetrahydro-4-[2,4,6-trimethyl-7-(4-nitrophenyl)-2,4,6-heptatrienylidene]-2-furanyl]-, (+)- |
J-017320 |
Q18392327 |
(+)-2-methoxy-3,5-dimethyl-6-[4-[7-(4-nitrophenyl)-2,4,6-trimethyl-2,4,6-heptatrienylidene]tetrahydrofuran-2-yl]-4h-pyran-4-one |
DTXSID101043872 |
Spectinabilin is a rare nitrophenyl-substituted polyketide metabolite.
Excerpt | Reference | Relevance |
---|---|---|
"Spectinabilin is a rare nitrophenyl-substituted polyketide metabolite. " | ( Cloning and heterologous expression of the spectinabilin biosynthetic gene cluster from Streptomyces spectabilis. Choi, YS; Johannes, TW; Lu, H; Shao, Z; Simurdiak, M; Zhao, H, 2010) | 2.07 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 9 (75.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.17) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |